Biological action of 1.1-dimethylhydrazine by Cornish, Herbert H. et al.
Short communications 1901 
Biochemical Pharmacology, 1965, Vol. 14, pp. 1901-1903. Permagon Press Ltd., Printed in Great Britain. 
Biological action of Ll-dimethylhydrazine* 
(Receiver1 23 June, 1965; accepted 3 August 1965) 
MANY papers have appeared in recent years concerning the toxicity and mechanism of action of 
hydrazine and 1,1-dimethylhydrazine (UDMH).l-9 Such studies have been stimulated by the use of 
these compounds as rocket fuels. The acute effect of UDMH on experimental animals is primarily 
a central nervous system toxicity resulting in clonic-tonic convulsions and death. 
A previous report10 indicated that amino acid excretion in rats was markedly increased after the 
intraperitoneal injection of UDMH. The present study evaluates several other biochemical criteria 
which might serve as indexes of exposure if they correlate with UDMH toxicity. These include the 
measurement of plasma iron levels and serum, erythrocyte, and brain cholinesterase activities. The 
diuretic effect of UDMH and the effect of intraperitoneal injections of various glutamic acid 
metabolites as possible antagonists of UDMH toxicity were investigated. Since many of these meta- 
bolites are not able to penetrate the blood-brain barrier at appreciable rates, it seemed likely that 
the direct injection of these materials into the brain might provide further information on their 
relationship to UDMH toxicity. 
MATERIALS AND METHODS 
UDMH was dissolved in 27 mM sodium bicarbonate in 0.9% saline just prior to use.” Other 
injected materials were dissolved in 0.9% saline. Male albino rats of the Sprague-Dawley strain 
(Rawley Farms) weighing 225-325 g were used throughout the studies. 
E&ct of UDMH on serum iron levels. Rats were injected i.p. with 40 to 80 mg UDMH/kg and 
sacrificed 24 hr later. The unhemolyzed sera from these animals and from normal rats were analyzed 
for iron according to the method of Fischl.ll 
Effect of UDMH on tissue and blood cholinesterase. Rats were injected i.p. with 100 mg UDMH/kg, 
and 4 hr later, heparinized blood was collected from surviving animals by heart puncture. The 
brains were immediately removed, weighed, and frozen on dry ice. Each brain was homogenized in 
24 volumes of cold distilled water and cholinesterase activity determined by a minor modification of 
the method of Frawley et ~1.1~ 
E&ct of glutamic acid and aminobutyric acid analogs on UDMH toxicity. Glutamic acid, a-amino- 
butyric acid (AABA), y-aminobutyric acid (GABA), and r-amino+hydroxybutyric acid (GABHBA) 
were studied for their effect on UDMH toxicity. Experimental groups consisted of six rats each, and all 
injections were intraperitoneal. Group I received 100 or 120 mg UDMH/kg. Group II received 
UDMH and the amino acid simultaneously. Group III received UDMH and the amino acid simul- 
taneously plus a second dose of amino acid 1 hr later. Group IV received two intraperitoneal doses 
of amino acid 1 hr apart. 
Intracerebral injection studies. Each rat was anesthetized with ether and an incision made along 
the sagittal line. The tissue was cleared from a point approximately 2 mm to the right of the sagittal 
suture and 2 mm posterior to the coronal suture. A small hole was drilled through the skull at that 
point and the intracerebral injection made with a stationary micrometer syringe and 26-gauge needle 
inserted to a depth of 3 mm from the skull surface. The test substances injected were UDMH, AABA, 
GABA, and GABHBA. Thirty pliters of sodium bicarbonate diluent and of 0.9 “/, saline were injected 
as maximal volume controls. The test substances were given in minimal volumes depending upon 
solubility and dosage. 
UDMH-induced diuresis. From 9 a.m. to 3 p.m. on two consecutive days, control urine samples 
were collected from each of six rats, the volumes recorded, and specific gravity determined gravi- 
metrically. On the third day each rat was given 80 mg UDMHjkg i.p., and 6-hr urine samples were 
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collected for two additional days. Animals were denied food and water during the 6-hr collection 
period. In a second study, 10 mg of UDMH was injected intracerebrally and urine samples collected 
as described above. 
KESU L’l-5: 
E#tief of UDMH on .serllt?l ir’an /eu&. Analysis of samples from 15 normal rats gave an average 
concentration of 433 _C 26 pg iron/l00 ml serum, compared to 455 : 16 for UDMH-treated rats. 
(Ail numerical results are given as the mean _i standard error.) There is no significant difference 
between treated and control groups. 
E’fect of’iJDMH on tissue and blood cholines/eruse. Plasma cholinesterase levels of UDMH-treated 
rats (0.85 :1 0.08) were slightly above those of control animals (0.63 .t 0.06). Brain and erythrocyte 
cholinesterase levels of UDMH-treated rats were 0.94 _k 0.02 and 0.18 .I: 0.01 respectively, not 
significantly different from those of control animals (brain: 0.91 : 0.01, erythrocytes: 0. I6 0.01). 
i#kcf of glutamic acid and omitzo/rrtyric acid analogs on UDMH foxiciry. Control rats given 500 
or 1,000 mg glutamic acid, AABA, GABA, or CABHBA i.p. per kg showed no abnormal behavior. 
Rats given both glutamic acid and UDMH convulsed and died at the same rate as rats given only 
UDMH. Animals receiving both AABA and UDMH exhibited an increased number of convulsions 
and a greater mortality rate (516) than rats receiving only 100 mg of UDMH per kg (2/6). CJABA 
or GABHBA (1,000 mg/kg) provided no significant protection against an LDloo dose of UDMH 
( I20 mg/kg). 
TAHOE 1. INTKACEREBRAL INJECTION OF UDMH AND WATAMIC ACID ME~ABOLIIES INI'O NORMAL K,WS 
Substance injected Amount 
his) 
No. convulsing No. dead 
0.9 % saline (30 *liters) 












0~24.0 O/9 o/9 
6.0-8.0 12119 




2.0 o/3 013 




intmce~ehru/i,licctions. Effectsof the intracerebralinjectionofanulnberofconlpoundsareshown 
in Table 1. Thirty pliters of 0.9% saline or of UDMH diluent produced no noticeable response in 
control rats. Four milligrams of UDMH elicited no response, but 6 to 8 mg caused convulsions 
(12/19) approximately 05 hr after injection. These convulsions were more severe as the dosage was 
increased. The minimal quantity of UDMH (6 mg) that produced convulsions when given intra- 
cerebrally had no effect when given intraperitoneally. 
Two tenths to 6 mg of AABA had no effect when injected intracerebrally into normal rats. 
Respiratory arrest, convulsions, and death occurred frequently when rats received from 4 to 9 mg 
of GABA intracerebrally. Doses of 2 to 6 mg of GABHBA generally produced respiratory arrest, 
which was followed by hyperactivity in resuscitated animals. When these compounds were injected 
intracerebrally into rats treated with 120 mg UDMH/kg, no protective effects were noted. 
Diuvesis studies. The average 6-hr urine volume of animals receiving 80 mg UDMH/kg was 6.8 ml, 
compared to I .8 ml for control rats (Table 2). In general, urine samples showed a considerable drop in 
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Five rats injected intracerebrally with UDMH diluent excreted normal amounts trf urine 
(1.2 :t 0.5 ml) after the injection. Four of six rats surviving a IO-mg intracerebral dose of UDMH 
excreted 3, 7, 20, and 26 ml of urine respectively during the subsequent 6-hr period. A similar dose 
of IO mg of UDMH given i.p. did not aller the urine volume. 
DISCUSSION 
A study of brain, plasma, and erythrocyte cholinesterase levels after UDMH injection indicates 
that cholincsterase inhibition does not play a role in UDMH convulsions nor can such measurements 
be used to assess the degree of acute exposure. The slight rise noted in plasma cholinesterasc levels 
of UDMH-treated rats may be related to convulsive seizures or to alterations of fluid balance brought 
on by diuresis. Similarly, serum iron levels in UDMH-treated rats were not different from controls 
and are not of value in assessing acute UDMH toxicity. 
Six or more milligrams of UDMH injected intracerebrally brings on convulsive seizures within 
half an hour, The usual time to onset of convulsions after the intraperitoneal injection of UDMH 
is 1.5 to 2 1ir.l” Thus, the direct injection of UDMH into brain markedly reduces the latent time before 
convulsions occur and will induce convulsions at dosages well below those required by other routes of 
injection. This finding suggests that the convulsive effect of UDMH is mediated directly in the brain 
and is not the result of UDMH metabolites formed in the liver or elsewhere in the body. On the basis 
of the metabolic blocks in glutamic acid metabolism produced by UDMH’, 8 it appeared possible 
that the intracerebral injection of one or more of these metabolites might alleviate the symptoms of 
UDMH toxicity. However, neither the intraperitoneal nor the intracerebral injection of varying 
amounts of AABA, CABA, or GABHBA protected rats from the toxic effects of UDMH. In normal 
rats these compounds are biologically active, producing convulsions and respiratory arrest in control 
animals when injected intracerebrdlly at relatively low dosages. 
Although urine output is markedly increased in UDMH-treated rats, the mechanisms involved and 
any relationship to the convulsive state remain to be clarified. An intracerebral injection of IO mg of 
UDMH produced a marked diuresis in rats. This amount given intraperitoneally has no diuretic 
elect, thus suggesting that the diuresis occurring in UDMH-treated rats may be initiated in the 
brain or in the pituitary. 
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